Glaucoma (Eye Pressure)
What is Glaucoma (eye pressure)?
Glaucoma is a group of eye disorders that damage the optic nerve, the bundle of nerve fibers that carries visual information from the eye to the brain. The most common form, primary open‑angle glaucoma, is closely linked to elevated intra‑ocular pressure (IOP). When the fluid inside the eye (aqueous humor) does not drain properly, pressure builds up, compressing the optic nerve fibers and gradually causing vision loss.
Glaucoma is often called the “silent thief of sight” because it can progress for years without noticeable symptoms. Early detection and treatment are essential to preserve vision.
Common Causes
While many cases are idiopathic (no clear cause), several conditions and risk factors can increase eye pressure and lead to glaucoma:
- Primary open‑angle glaucoma – the most prevalent type; drainage angle remains open but the trabecular meshwork works inefficiently.
- Angle‑closure (narrow‑angle) glaucoma – the iris bulges forward, blocking drainage and causing a rapid pressure spike.
- Secondary glaucoma – result of another eye disease or injury (e.g., uveitis, cataract surgery, trauma).
- Pseudoexfoliation syndrome – accumulation of flaky material on eye structures that clogs drainage pathways.
- High myopia (nearsightedness) – elongates the eye, stretching the optic nerve and increasing susceptibility.
- Genetic factors – family history of glaucoma raises risk by up to 5‑fold.
- Systemic conditions – diabetes, hypertension, and hypothyroidism can affect ocular blood flow and pressure.
- Long‑term corticosteroid use – topical eye drops, inhaled, or oral steroids may raise IOP.
- Eye injuries or tumors – trauma or intra‑ocular tumors can obstruct fluid outflow.
- Age – risk roughly doubles after age 60.
Associated Symptoms
In early stages, many people have no symptoms. When signs appear, they may include:
- Gradual loss of peripheral (side) vision, often unnoticed at first.
- Blurred vision or difficulty seeing in dim light.
- Halos around lights, especially at night (more common in angle‑closure glaucoma).
- Eye pain or a feeling of pressure (usually acute in angle‑closure crises).
- Redness of the eye (often with acute angle‑closure).
- Headache, especially above the eyes.
- Nausea or vomiting (typically with very high pressure in an acute attack).
When to See a Doctor
Prompt evaluation is crucial if you notice any of the following:
- Sudden eye pain, especially if accompanied by nausea, vomiting, or blurred vision.
- Seeing halos around lights or experiencing a “rainbow‑like” effect.
- Rapid loss of vision, even if it’s just a small area.
- Eye redness that does not improve with over‑the‑counter drops.
- Any change in peripheral vision (e.g., missing objects on the edges of your visual field).
- History of eye trauma, steroid use, or a family member with glaucoma.
If you belong to a high‑risk group (age > 60, African or Hispanic ancestry, thin corneas, high myopia), schedule a comprehensive eye exam at least once every two years, even without symptoms.
Diagnosis
Diagnosing glaucoma involves a series of tests that evaluate pressure, optic nerve health, and visual field integrity:
- Tonometry – measures intra‑ocular pressure. The most common method is applanation tonometry; a reading > 21 mmHg is considered elevated, though glaucoma can occur at lower pressures.
- Gonioscopy – uses a special lens to view the drainage angle, determining whether it is open or closed.
- Ophthalmoscopy / Fundoscopy – the doctor examines the optic nerve head for characteristic cupping (enlarged optic disc with thinning of the neuro‑retinal rim).
- Optical Coherence Tomography (OCT) – provides high‑resolution cross‑sectional images of the retinal nerve fiber layer, detecting early thinning.
- Visual Field Testing (Perimetry) – maps the peripheral vision to identify blind spots that develop with glaucoma.
- Pachymetry – measures corneal thickness, which influences IOP readings and risk assessment.
Because glaucoma can be asymptomatic, regular screening is the only reliable way to catch it early.
Treatment Options
Glaucoma treatment aims to lower intra‑ocular pressure to a level that halts further optic nerve damage. Management usually involves a combination of medications, laser procedures, and surgery.
Medications (Medical Therapy)
- Prostaglandin analogues (e.g., latanoprost, bimatoprost) – increase outflow through the uveoscleral pathway; usually first‑line.
- Beta‑blockers (e.g., timolol, betaxolol) – reduce aqueous humor production.
- Alpha‑agonists (e.g., brimonidine) – both decrease production and increase outflow.
- Carbonic anhydrase inhibitors (e.g., dorzolamide, oral acetazolamide) – lower production.
- Rho‑kinase inhibitors (e.g., netarsudil) – newer agents that improve trabecular outflow.
Adherence is critical; missing doses can cause pressure spikes. Common side effects include eye redness, burning, blurred vision, or systemic effects with beta‑blockers (e.g., low heart rate).
Laser Treatments
- Selective Laser Trabeculoplasty (SLT) – targets pigmented cells in the trabecular meshwork, enhancing drainage; often used in open‑angle glaucoma.
- Argon Laser Peripheral Iridotomy (ALPI) – creates a small hole in the peripheral iris to relieve angle‑closure pressure.
- Laser Cyclophotocoagulation – reduces aqueous production by partially destroying the ciliary body (reserved for refractory cases).
Surgical Options
- Trabeculectomy – creates a new drainage channel beneath the conjunctiva; considered the gold‑standard for advanced disease.
- Glaucoma drainage devices (tube shunts) – implant a small tube that channels fluid to an external reservoir.
– includes iStent, Hydrus, and Trabectome; smaller incisions, quicker recovery, but modest pressure reduction.
Adjunctive Home Measures
- Maintain a healthy weight; obesity is linked to higher IOP.
- Exercise regularly (e.g., brisk walking, swimming) – moderate aerobic activity may modestly lower pressure.
- Limit caffeine intake; high amounts can cause temporary IOP spikes.
- Avoid smoking, which impairs ocular blood flow.
- Use protective eyewear to prevent trauma.
Prevention Tips
While you cannot change genetic risk, lifestyle and regular eye care can reduce the chance of developing glaucoma or slow its progression:
- Schedule regular eye exams – at least once every 1‑2 years after age 40, more often if you have risk factors.
- Know your family history – share it with your optometrist or ophthalmologist.
- Manage systemic diseases – keep blood pressure and blood sugar under control.
- Use steroids sparingly – discuss alternatives with your physician; if you must use them, request periodic IOP monitoring.
- Protect your eyes – wear safety goggles during sports or work that involves debris.
- Stay hydrated – dehydration can concentrate aqueous humor, potentially raising pressure.
Emergency Warning Signs
- Sudden, severe eye pain or a feeling of pressure
- Rapid vision loss or “blackening” of vision
- Halos or rainbow‑colored rings around lights
- Redness of the eye, especially the white part
- Nausea, vomiting, or severe headache accompanying eye symptoms
Key Takeaways
Glaucoma is a leading cause of irreversible blindness worldwide. Elevated eye pressure is the primary modifiable factor, but the disease can develop even with normal pressures. Early detection through routine retinal and pressure testing, combined with consistent treatment, can preserve sight for a lifetime. If you belong to a high‑risk group or notice any warning signs, do not wait—schedule an eye exam promptly.
References
- Mayo Clinic. “Glaucoma – Symptoms and causes.” https://www.mayoclinic.org/diseases-conditions/glaucoma/symptoms-causes/syc-20372839
- American Academy of Ophthalmology. “Glaucoma Overview.” https://www.aao.org/eye-health/diseases/what-is-glaucoma
- National Eye Institute (NEI). “Facts About Glaucoma.” https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/glaucoma
- Cleveland Clinic. “Glaucoma Treatment Options.” https://my.clevelandclinic.org/health/diseases/11272-glaucoma
- World Health Organization. “World Report on Vision.” 2022. https://www.who.int/publications/i/item/9789240064808